AaronSMansfieldMD

PubMed

• 4 citations
  Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positi...
  Kaushal Parikh, Anastasios Dimou, Konstantinos Leventakos, Aaron S Mansfield, Mohamed Shanshal
  Journal of Thoracic Oncology. 2024-11-01
• 1 citations
  Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma.
  Aaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, David J Kwiatkowski, Shiven Patel
  Lung Cancer. 2024-09-01
• 5 citations
  Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous-Wildtype Non-Small Cell Lung Cancer in the Phas...
  D Ross Camidge, Jair Bar, Hidehito Horinouchi, Jonathan Goldman, Fedor Moiseenko
  Journal of Clinical Oncology. 2024-09-01

Journal Articles

• Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials  
  Mansfield AS, Symanowski JT, Peikert T, Lung Cancer, 1/1/2014
• Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis  
  Phan M, John S, Casanegra AI, Rathbun S, Mansfield A, Stoner JA, Tafur AJ, J Thromb Thrombolysis, 1/1/2014

Books/Book Chapters

• The 5-minute clinical consult 
  Chapter: von Willebrand Disease 
  Page 1420 - 1421Mansfield ASEditors: Domino FJ.Lippincott Williams & Wilkins, Philadelphia, PA2010

Abstracts/Posters

• Programmed cell death 1 ligand 1 expression and association with survival in mesothelioma
  Mansfield AS, Peikert T, Roden A, Krco C, Harrington S, Dong H, Kwon E, Thorac Oncol, 1/1/2014
• Immune cell profile of the sln has prognostic value in stage iii melanoma
  Grotz TE, Mansfield AS, Jakub JW, Markovic SN, Hieken TJ, Cancer Res, 1/15/2013
• Dna methylation and expression patterns in adenocarcinomas of the lung of never-smokers with discordant methylation and expression patterns of homeobox related genes
  Mansfield AS, Wang L, Cunningham JM, Jen J, Kolbert C, Sun ZF, Yang P, J Thorac Oncol, 1/1/2013
• Skin surveillance and malignancies in patients with chronic lymphocytic leukemia
  Mansfield AS, ASCO Quality Care Symposium, San Diego, CA, 1/1/2012
• Immunologic changes in patients with metastatic melanoma on bevacizumab and chemotherapy versus chemotherapy alone
  Mansfield AS, Nevala WK, Markovic SN, Journal of Clinical Oncology, 1/1/2012
• Aging is associated with an increase in regulatory T cells, MCP-1 and RANTES
  Mansfield A, Nevala W, Dronca R, Leontovich A, Markovic S, J Immunol, 1/1/2012
• Comparison on fluorescence in situ hybridization and dual-in situ hybridization in the determination of HER2 status in breast cancer
  Mansfield AS, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2012
• Effects of bevacizumab on systemic immunity in the treatment of metastatic
  Mansfield AS, ASCO Markers in Cancer, Hollywood, FL, 1/1/2012
• Aging is associated with an increase in TH2 cells, MCP-1 and RANTES
  Mansfield AS, Immunology (American Association of Immunologists), Boston, MA, 1/1/2012
• Mayo Clinic experience with rare exocrine pancreatic neoplasms
  Mansfield AS, ASCO Gastrointestinal Cancers Symposium, 1/1/2010
• Regional Immunity in Melanoma: Immunosuppressive Changes Precede Nodal Metastasis
  Mansfield AS, ASCO, Chicago, IL, 1/1/2010
• Using fetomaternal interactions to identify immunomodulatory mechanisms in melanoma
  Holtan SG, Mansfield AS, Creedon DJ, Nevala WK, Leontovich AA, Markovic SN, Placenta, 1/1/2010
• Regional Immunity in Melanoma: Immunosuppressive Changes Precede Nodal Metastasis
  Mansfield AS, Holtan SG, Grotz TE, Allred JB, Jakub JW, Erickson LA, Flotte TJ, Markovic SN, Journal of Clinical Oncology, 1/1/2010
• Regional Immunity in Melanoma
  Mansfield AS, NIH Frontiers in Basic Immunology, Bethesda, MD, 1/1/2009
• Topical peptide immunization with NY-ESO-1B peptide (SLLMWITQC) using resiquimod as an immune djuvant
  Mansfield A, Kottschade L, McWilliams R, Creagan E, Kaur J, Croghan G, Quevedo F, Markovic S, J Immunother, 1/1/2009
• Reproductive assistance gone amiss: Pulmonary embolism in a 30 year-old female with ovarian hyperstimulatory syndrome
  Mansfield AS, Society of General Internal Medicine Mountain West meeting, Tempe, AZ, 1/1/2008
• VEGF-C in association with VEGFR-3 promotes nodal metastases in breast cancer with extensive intraductal component
  Van Iterson, Heikkila P, Mansfield AS, von Smitten K, Leidenius M, European Journal of Cancer, 1/1/2008
• Lost in Translation: 47 year-old gentleman with sound-induced vertigo
  Mansfield AS, American College of Physicians Minnesota chapter meeting, Minneapolis, MN, 1/1/2008
• Swallowing Systole
  Mansfield AS, Society of General Internal Medicine Midwest meeting, Chicago, IL, 1/1/2008
• VEGF-C in association with VEGFR-3 promotes nodal metastases in breast cancer with extensive intraductal component
  Mansfield AS, 6th European Breast Cancer Conference, Berlin, Germany, 1/1/2008
• Decreased accumulation of CD163-positive macrophages is associated with nodal metastases in patients with breast cancer
  Mansfield AS, Heikkila P, Vakkila J, von Smitten K, Leidenius M, Breast Cancer Research and Treatment, 1/1/2007
• Spontaneous episodic hypothermia with hyperhidrosis in a patient with HIV-1
  Mansfield AS, American College of Physicians Minnesota Chapter Scientific Meeting, Minneapolis, MN, 1/1/2007
• Decreased accumulation of CD163-positive macrophages is associated with nodal metastases in patients with breast cancer
  Mansfield AS, 30th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2007
• Foxp3-positive regulatory T cells are associated with nodal stratus in breast cancer
  Mansfield AS, Heikkila P, Vakkila J, von Smitten K, Leidenius M, Breast Cancer Research and Treatment, 1/1/2006
• Foxp3-positive regulatory T cells are associated with nodal stratus in breast cancer
  Mansfield AS, Vakkila J, Heikkila P, von Smitten K, Leidenius M, Journal of Immunotherapy, 1/1/2006
• Join now to see all

Lectures

• Identifying Appropriate Trials for Our Patients and Considering Compassionate Use Programs 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
• LB-100: Rethinking protein phosphorylation 
  Santa Monica, CA - 1/1/2014
• Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials 
  Cape Town, South Africa (2014); Perth, Australia (2014) - 1/1/2014
• The Potential of Immune Checkpoint Inhibition in Mesothelioma 
  Perth, Australia - 1/1/2014
• Programmed Cell Death 1 Ligand 1 Expression and Association with Survival in Mesothelioma 
  Geneva, Switzerland - 1/1/2014
• Lung Cancer Updates 
  Denver, CO - 1/1/2014
• Melanoma Peptide Vaccines: Lessons in Immunosuppression 
  Beijing, China - 1/1/2012
• Regional Immunity in Melanoma 
  Indianapolis, IN - 1/1/2011
• Treating Chronic Myeloid Leukemia in Nepal: Cytogenetic techniques and result interpretation 
  Patan, Nepal - 1/1/2011
• Join now to see all